PRE DIAGNOSTICS AS
Operating
Utvikling og salg av diagnostiske tester samt annen virksomhet som
står i forbindelse med dette.
Industri: Utvikling og salg av diagnostiske tester.
Organization
- CEO
- HS
Håkon Sæterøy1958
- Chairman of the board
- OP
- Years since formation
- 13 years
- since Nov 12, 2013
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 12
Ownership
- Number of shares and share classes
- 440,226
- 1 share class
- Total number of shareholders
- 46
- 29 companies, 17 persons
- Belongs to group of
Financials
- Total operating income 2025
- 15,758,267
- NOK
- Annual total result 2025
- -6,843,907
- NOK
- Total equity 2025
- 741,670
- NOK
Last update: Jul 16, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
HS 1958 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
OP | Chairman | - |
SC | Board Member | - |
NB 1955 | Board Member | - |
MS | Board Member | - |
BN 1970 | Board Member | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
SH 1958 | - | 12.93 % directly 4.54 % indirectly 8.39 % |
BN 1955 | - | 12.9 % indirectly |
CE 1956 | - | 6.71 % directly |
PN 1954 | - | 3.49 % directly 0.06 % indirectly 3.43 % |
TH 1946 | - | 2.96 % indirectly |
OT | - | 2.51 % indirectly |
CK | - | 1.59 % directly |
| - | 1.36 % indirectly | |
| - | 1.36 % indirectly | |
TL | - | 1.36 % indirectly |
Last update: Sep 9, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 56,800 | 12.9 % | |
| Ordinary shares | 51,133 | 11.62 % | |
| Ordinary shares | 38,480 | 8.74 % | |
| Ordinary shares | 30,000 | 6.81 % | |
CE 1956 | Ordinary shares | 29,541 | 6.71 % |
| Ordinary shares | 27,500 | 6.25 % | |
| Ordinary shares | 27,250 | 6.19 % | |
SH 1958 | Ordinary shares | 20,000 | 4.54 % |
| Ordinary shares | 18,000 | 4.09 % | |
| Ordinary shares | 11,028 | 2.51 % | |
| Ordinary shares | 9,680 | 2.2 % | |
| Ordinary shares | 8,500 | 1.93 % | |
| Ordinary shares | 7,020 | 1.59 % | |
CK | Ordinary shares | 6,985 | 1.59 % |
| Ordinary shares | 5,000 | 1.14 % | |
BB | Ordinary shares | 5,000 | 1.14 % |
| Ordinary shares | 4,500 | 1.02 % | |
HA 1955 | Ordinary shares | 4,150 | 0.94 % |
AW | Ordinary shares | 3,800 | 0.86 % |
| Ordinary shares | 3,704 | 0.84 % | |
| Ordinary shares | 2,700 | 0.61 % | |
| Ordinary shares | 2,500 | 0.57 % | |
| Ordinary shares | 2,500 | 0.57 % | |
| Ordinary shares | 2,223 | 0.5 % | |
| Ordinary shares | 2,100 | 0.48 % | |
| Ordinary shares | 1,500 | 0.34 % | |
| Ordinary shares | 1,500 | 0.34 % | |
| Ordinary shares | 1,482 | 0.34 % | |
SB | Ordinary shares | 1,000 | 0.23 % |
SE | Ordinary shares | 1,000 | 0.23 % |
K Closed | Ordinary shares | 1,000 | 0.23 % |
FH | Ordinary shares | 1,000 | 0.23 % |
| Ordinary shares | 740 | 0.17 % | |
EK | Ordinary shares | 500 | 0.11 % |
TK 1968 | Ordinary shares | 500 | 0.11 % |
| Ordinary shares | 500 | 0.11 % | |
| Ordinary shares | 500 | 0.11 % | |
| Ordinary shares | 500 | 0.11 % | |
| Ordinary shares | 500 | 0.11 % | |
EL | Ordinary shares | 370 | 0.08 % |
| Ordinary shares | 370 | 0.08 % | |
| Ordinary shares | 330 | 0.07 % | |
PN 1954 | Ordinary shares | 250 | 0.06 % |
LF | Ordinary shares | 200 | 0.05 % |
DH 1971 | Ordinary shares | 140 | 0.03 % |
SS 1973 | Ordinary shares | 100 | 0.02 % |
Shares owned by the PRE DIAGNOSTICS AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 30,000 | 100 % | |
| Ordinary shares | 30,000 | 75 % |
Last update: Sep 25, 2026
Group structure
- Total operating income 2025: NOK 15,758,267Operating profit 2025: NOK -6,417,159Employees: 12
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 15,758,267 | 9,802,205 | 11,716,120 | 6,037,493 | 9,751,627 |
Annual Total Result | -6,843,907 | -11,524,714 | -3,761,149 | -6,526,277 | -5,458,662 |
Total assets | 16,056,762 | 19,064,391 | 15,054,468 | 12,054,407 | 8,868,599 |
Total liabilities | 15,315,091 | 11,673,813 | 8,114,176 | 7,977,607 | 3,017,372 |
Total equity | 741,670 | 7,390,578 | 6,940,291 | 4,076,800 | 5,851,227 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 15,758,267 | 9,802,205 | 11,716,120 | 6,037,493 | 9,751,627 |
Total operating costs | 22,175,425 | 20,631,968 | 15,349,163 | 12,464,629 | 15,209,928 |
Operating result | -6,417,159 | -10,829,762 | -3,633,043 | -6,427,136 | -5,458,301 |
Financial income/costs | -426,749 | -694,951 | -128,106 | -99,141 | -361 |
Profit before tax | -6,843,907 | -11,524,714 | -3,761,149 | -6,526,277 | -5,458,662 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -6,843,907 | -11,524,714 | -3,761,149 | -6,526,277 | -5,458,662 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 7,439,755 | 9,011,966 | 9,101,157 | 5,846,043 | 1,345,902 |
Total current assets | 8,617,007 | 10,052,425 | 5,953,311 | 6,208,364 | 7,522,697 |
Total assets | 16,056,762 | 19,064,391 | 15,054,468 | 12,054,407 | 8,868,599 |
Short term debt | 8,860,129 | 5,073,403 | 6,498,318 | 6,266,301 | 3,017,372 |
Long term debt | 6,454,962 | 6,600,410 | 1,615,858 | 1,711,306 | 0 |
Total liabilities | 15,315,091 | 11,673,813 | 8,114,176 | 7,977,607 | 3,017,372 |
Contributed capital | 741,670 | 7,390,578 | 6,940,291 | 4,076,800 | 36,292,729 |
Retained earnings | 0 | 0 | 0 | 0 | -30,441,502 |
Total equity | 741,670 | 7,390,578 | 6,940,291 | 4,076,800 | 5,851,227 |
Total equity and liabilities | 16,056,762 | 19,064,391 | 15,054,468 | 12,054,407 | 8,868,599 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification